Policy
Ken Griffin Boosts AbbVie Stake 547% as Dividend King Yields 2.8%
Hedge fund manager Ken Griffin significantly expanded his position in healthcare giant AbbVie (ABBV), increasing his stake by 547%. This move underscores interest in AbbVie's strong dividend yield of approximately 2.8% and its consistent history of dividend growth, a trait that has earned it 'Dividend King' status.
oil gasutilitiesclean energy
- Citadel's significant increase in AbbVie highlights the appeal of the company's dividend yield (2.8%) and its track record as a Dividend King. - Investors seeking income and dividend growth may find AbbVie's sustained dividend increases and expanding immunology portfolio attractive.
